About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lymphoma Clinical Trials | 6,589 Studies Recruiting

Clinical TrialsLymphoma

Lymphoma Clinical Trials

Browse 6,589 clinical trials for lymphoma. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4181-4200 of 6,589 trials

CompletedOxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasThis phase I trial is studying the side effects and best dose of oxaliplatin when given together with irinotecan in treating young patients with refractory solid tumors or…NCT00101270·Arcadia, California CompletedCombination of SAR3419 and Rituximab in Relapsed/Refractory Diffuse Large B-Cell LymphomaPrimary Objective: Participants Achieving an Objective Response Rate (Cheson 2007) Secondary Objectives: * Progression Free Survival * Overall Survival * Response DurationNCT01470456·Graz and 12 others

Related Searches

hodgkintrials non-hodgkintrials

Data from ClinicalTrials.govTerms

TerminatedGemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary SyndromeRATIONALE: Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from…NCT00369629·Chicago, Illinois

TerminatedRituximab Maintenance After Autologous TransplantationThe goal of this clinical research is to see if Rituxan (rituximab) therapy given after high dose chemotherapy and transplant of a patients own stem cells will prevent or delay…NCT01103388·Houston, Texas

CompletedRelapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell TherapyThis is a multicenter Phase 1b study evaluating the safety, tolerability, and preliminary anti-tumor activity of NT-I7 administration following standard of care CD19 chimeric…NCT05075603·Duarte, California and 2 others

CompletedA Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's LymphomaThis is a Phase 1, open-label, multicenter study evaluating the safety, pharmacokinetic profile, and preliminary efficacy of ABT-199 in combination with Bendamustine/Rituximab in…NCT01594229·La Jolla, California and 7 others

CompletedChemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die.NCT00003661·Gainesville, Florida and 16 others

CompletedTreatment of Severe Influenza A InfectionEach year, influenza A infection caused great mortality and morbidity, especially among the elderly and individuals with chronic illness.NCT02108366·Hong Kong

CompletedOral Panobinostat Adult Patients DLBCL Relapsed/Refractory Stem Cell Transfusion (ASCT) or Not Eligible for ASCTTreatment of adult patients with Diffuse Large B-cell Lymphoma (DLBCL), relapsed or refractory to previous CHOP-R (or CHOP-R like regimen) front line therapy, relapsed or…NCT01523834·Alessandria and 9 others

CompletedShort Term Intensified Chemo-immunotherapy in HIV-positive Patients With Burkitt LymphomaThis is a multicenter,open-label trial to evaluate activity and safety of the investigational intensive in HIV+ patients with Burkitt's lymphoma.NCT01516593·Aviano (PN) and 7 others

TerminatedAspen™ Ultrasound System and Aspen Rehabilitation Technique in the Treatment of Capsular ContracturePurpose: The purpose of this investigation is to test the safety and effectiveness of the Aspen System™ and Aspen Rehabilitation Technique.NCT02840084·New York, New York

CompletedInfusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T CellsThe goal of this clinical research study is to learn if an infusion of white blood cells (called T cells) that have been genetically changed is safe to give patients who have…NCT01362452·Houston, Texas

UnknownEffectiveness and Cost-effectiveness of Telephone-delivered Psychotherapy for Depression in Primary CareThe aim of the study is the examination of effectiveness and cost-effectiveness of a telephone-based psychotherapy (Tel-PT) for depression compared to treatment as usual in…NCT02667366·Zurich

CompletedErythropoietin for Management of Anemia Caused by ChemotherapyThis is a phase Ⅱ study of erythropoietin for management of anemia caused by chemotherapy in patients with Diffuse Large B-cell Lymphoma.NCT02890602

CompletedCombination Chemotherapy, Peripheral Stem Cell Transplantation, and Biological Therapy in Treating Patients With Solid Tumors or LymphomaRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00027937·Seattle, Washington

CompletedTreatment for Advanced B-Cell LymphomaTo safely reduce the burden of therapy in children, adolescents and young adults with mature B-NHL by reducing the number of intrathecal (IT) injections by the introduction of IT…NCT01859819·Buffalo, New York and 4 others

CompletedA Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL)This Phase Ib/II, open-label, multicenter, non-randomized study will evaluate the safety, efficacy, and pharmacokinetics of induction treatment consisting of atezolizumab in…NCT02596971·Aurora, Colorado and 20 others

CompletedPRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily EnzastaurinThis clinical research study is to investigate the prevention of relapse in patients with diffuse large B cell lymphoma (DLBCL) using enzastaurin daily.NCT00332202·Anchorage, Alaska and 152 others

CompletedDexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell LymphomaRATIONALE: Denileukin diftitox may be able to deliver cancer-killing substances directly to T-cell lymphoma cells.NCT00006345·Miami, Florida and 10 others

RecruitingStudy of SGR-1505 in Mature B-Cell NeoplasmsThe purpose of this study is to evaluate safety and tolerability and to determine the maximum tolerated dose (MTD) or maximum administered dose (MAD) and/or recommended dose (RD)…NCT05544019·Gilbert, Arizona and 35 others

PreviousPage 210 of 330Next